Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer’s Disease

Alzheimer’s disease (AD) is one of the most common progressive neurodegenerative diseases, accompanied by global alterations in metabolic profiles. In the past 10 years, over hundreds of metabolomics studies have been conducted to unravel metabolic changes in AD, which provides insight into the iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Zhao, Hu, Tian, Su, Shijie, Liu, Jinman, Ma, Yinzhong, Zhuo, Yue, Fang, Shuhuan, Wang, Qi, Mo, Zhizhun, Pan, Huafeng, Fang, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174950/
https://www.ncbi.nlm.nih.gov/pubmed/35694256
http://dx.doi.org/10.3389/fphar.2022.904857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174950/
https://www.ncbi.nlm.nih.gov/pubmed/35694256
http://dx.doi.org/10.3389/fphar.2022.904857

Ejemplares similares